By Julia Werdigier Novartis, one of Switzerland’s biggest drug makers, said Tuesday it scrapped a planned $78 million payment to its departing chairman because of
Bruce Wasserstein, the Wall Street investment banker who helped pioneer the hostile takeover in the 1980s and reshaped the mergers and acquisitions business into a
